Cresco Labs Inc.: Form 40-F for the period ended Dec 31, 2024
Filed with the SEC on Mar 14, 2025 and accepted by EDGAR at Mar 14, 2025, 16:46 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2024-01-01 to 2024-12-31 | $724.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2024-01-01 to 2024-12-31 | $359.9m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months2024-01-01 to 2024-12-31 | $364.5m | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months2024-01-01 to 2024-12-31 | $254.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2024-01-01 to 2024-12-31 | $107.3m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2024-01-01 to 2024-12-31 | $49.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2024-01-01 to 2024-12-31 | −$74.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2024-01-01 to 2024-12-31 | −$0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2024-01-01 to 2024-12-31 | −$0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2024-01-01 to 2024-12-31 | 345,474,155 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2024-01-01 to 2024-12-31 | $132.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2024-01-01 to 2024-12-31 | $19.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2024-12-31 | $137.6m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $294.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $1.36bn | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $94.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-12-31 | $967.2m | us-gaap:Liabilities |
| Long-term debt | At period end2024-12-31 | $460.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2024-12-31 | $2.6m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2024-12-31 | $11.9m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-12-31 | $474.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001832928-25-000006. Last ingested by Listed: Nov 6, 2026, 12:03 ET. Listed shows no prices and gives no investment advice.